Old Web
English
Sign In
Acemap
>
authorDetail
>
Shannon Lubaczewski
Shannon Lubaczewski
Desvenlafaxine
Medicine
Pharmacology
Pharmacokinetics
Confidence interval
5
Papers
85
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Open-label, 2-period sequential drug interaction study to evaluate the effect of a 100-mg dose of desvenlafaxine on the pharmacokinetics of tamoxifen when coadministered in healthy postmenopausal female subjects.
2014
CP | Principles and Practice of Constraint Programming
Alice I. Nichols
Shannon Lubaczewski
Yali Liang
Kyle Matschke
Gabriel Braley
Tanya Ramey
Show All
Source
Cite
Save
Citations (4)
Real-world disparities between patient- and clinician-reported outcomes: results from a disease-specific program in depression and anxiety.
2014
Professional case management
Shannon Lubaczewski
Jason Shepherd
Rana Fayyad
Christine J. Guico-Pabia
Show All
Source
Cite
Save
Citations (6)
An Open-Label Evaluation of the Effect of Coadministering Desvenlafaxine100 mg on the Pharmacokinetics of Aripiprazole in Healthy Subjects
2013
Journal of Bioequivalence & Bioavailability
Alice I. Nichols
Shannon Lubaczewski
Yali Liang
Kyle Matschke
Gabriel Braley
Tanya Ramey
Show All
Source
Cite
Save
Citations (4)
An Evaluation of the Potential of Cytochrome P450 3A4-Mediated Drug-Drug Interactions with Desvenlafaxine Use
2013
Journal of Bioequivalence & Bioavailability
Alice I. Nichols
Yali Liang
Kyle Matschke
Jeffrey Paul
Jessica Behrle
Joel A Posener
Alain Patat
Shannon Lubaczewski
Gabriel Braley
Tanya Ramey
Show All
Source
Cite
Save
Citations (6)
Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo.
2011
Journal of Clinical Psychopharmacology
Boadie W. Dunlop
Sujana Reddy
Lingfeng Yang
Shannon Lubaczewski
Kristen Focht
Christine J. Guico-Pabia
Show All
Source
Cite
Save
Citations (65)
1